Bausch & Lomb Corp SEC filings BLCO

Bausch & Lomb Corp has 371 filings in SEC EDGAR's recent list, going back to May 27, 2021. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change). The company's fiscal year ends on December 31.

Bausch & Lomb Corp SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 28, 2026 Oct 28, 2026
10-Q Quarterly report Oct 28, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 13, 2026 Oct 11, 2026
8-K/A Amended current report
Officer or director change
Aug 12, 2026 Aug 5, 2026
8-K Current report
Material agreement, Officer or director change, Other events
Aug 6, 2026 Aug 5, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
8-K Current report
Shareholder vote results
May 20, 2026 May 20, 2026
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 10, 2026 May 20, 2026
10-K Annual report Feb 18, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 18, 2026 Feb 18, 2026
8-K Current report
Material agreement, New debt, Other events
Jan 2, 2026 Jan 2, 2026
8-K/A Amended current report
Officer or director change
Dec 22, 2025 Dec 17, 2025
8-K Current report
Officer or director change
Dec 17, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 12, 2025 Dec 12, 2025
8-K Current report
Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Agreement ended, Officer or director change, Regulation FD disclosure
Aug 18, 2025 Aug 14, 2025
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Officer or director change
Jul 23, 2025 Jul 21, 2025
8-K Current report
Material agreement, New debt, Other events
Jun 27, 2025 Jun 26, 2025
8-K Current report
Other events
Jun 18, 2025 Jun 18, 2025
8-K Current report
Other events
Jun 10, 2025 Jun 10, 2025
SD Specialized disclosure (conflict minerals) May 30, 2025 —
8-K Current report
Shareholder vote results
May 21, 2025 May 21, 2025
DEFA14A Additional proxy material May 21, 2025 —
8-K Current report
Other events
May 21, 2025 May 19, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 10, 2025 May 21, 2025
10-K Annual report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 19, 2025 Feb 19, 2025
8-K Current report
Material agreement, New debt
Nov 1, 2024 Nov 1, 2024
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
S-8 Employee stock plan registration Aug 1, 2024 —
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2024 May 29, 2024
10-Q Quarterly report May 1, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 1, 2024 May 1, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 May 29, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 28, 2024 Feb 27, 2024
10-K Annual report Feb 21, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 21, 2024 Feb 21, 2024
8-K/A Amended current report Nov 13, 2023 Sep 29, 2023
8-K/A Amended current report
Officer or director change
Nov 7, 2023 Jun 1, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, New debt
Sep 29, 2023 Sep 29, 2023
8-K Current report
Other events
Sep 14, 2023 Sep 14, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
8-K Current report
Regulation FD disclosure
Sep 6, 2023 Sep 6, 2023
8-K/A Amended current report
Officer or director change
Aug 29, 2023 Apr 10, 2023
S-8 Employee stock plan registration Aug 2, 2023 —
S-3ASR Automatic shelf registration Aug 2, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Material agreement
Jul 7, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 30, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Jun 1, 2023 Jun 1, 2023
10-Q Quarterly report May 3, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 3, 2023 May 3, 2023
8-K Current report
Officer or director change, Shareholder vote results
Apr 26, 2023 Apr 24, 2023
8-K Current report
Officer or director change
Apr 12, 2023 Apr 10, 2023
ARS Annual report to shareholders Mar 13, 2023 Dec 31, 2022
DEFA14A Additional proxy material Mar 13, 2023 —
DEF 14A Proxy statement Mar 13, 2023 —
10-K Annual report Feb 22, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 22, 2023 Feb 22, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 15, 2023 Feb 14, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 22, 2022 Dec 22, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 2, 2022 Nov 2, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 27, 2022 Jul 25, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 20, 2022 Jul 14, 2022
8-K Current report
Material agreement, Officer or director change
Jun 23, 2022 Jun 21, 2022
10-Q Quarterly report Jun 8, 2022 Mar 31, 2022
8-K Current report
Results of operations
Jun 8, 2022 Jun 8, 2022
8-K Current report
Results of operations
May 17, 2022 May 16, 2022
8-K Current report
Material agreement, Bylaw or fiscal year change, Other events
May 10, 2022 May 5, 2022
424B4 Prospectus May 6, 2022 —
S-8 Employee stock plan registration May 6, 2022 —
EFFECT Filing May 5, 2022 —
CERT Nyse certification May 5, 2022 —
8-A12B Filing May 5, 2022 —
CORRESP Letter to the SEC May 3, 2022 —
CORRESP Letter to the SEC May 3, 2022 —
CORRESP Letter to the SEC Apr 28, 2022 —
CORRESP Letter to the SEC Apr 28, 2022 —
S-1/A Amended registration statement Apr 28, 2022 —
UPLOAD Letter from the SEC Apr 27, 2022 —
UPLOAD Letter from the SEC Apr 13, 2022 —
S-1/A Amended registration statement Mar 31, 2022 —
CORRESP Letter to the SEC Jan 13, 2022 —
S-1 Registration statement Jan 13, 2022 —
UPLOAD Letter from the SEC Dec 1, 2021 —
DRSLTR Filing Nov 19, 2021 —
DRS/A Filing Nov 19, 2021 —
UPLOAD Letter from the SEC Sep 17, 2021 —
DRSLTR Filing Sep 3, 2021 —
DRS/A Filing Sep 3, 2021 —
DRSLTR Filing Aug 6, 2021 —
UPLOAD Letter from the SEC Jul 20, 2021 —
DRSLTR Filing Jul 9, 2021 —
DRS/A Filing Jul 9, 2021 —
UPLOAD Letter from the SEC Jun 24, 2021 —
DRS Filing May 27, 2021 —

Showing 119 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Ophthalmic Goods (SIC 3851)
Listed as
BLCO (NYSE)
Fiscal year ends
December 31
Headquarters
Vaughan, Ontario, Canada
SEC filer status
Large accelerated filer
SEC CIK
1860742

Other Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.